1-6 of 6
Duygu Bozkaya
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Patterns of Additional Factor Treatment Use Among Hemophilia a Patients on Regular Prophylaxis in the United States: Results from the Picnichealth Database

Jonathan C. Roberts, Angela C Weyand, Mark T Reding, Nana Kragh, Nicole Tsao, Emily Cibelli, Gillian Hanson, Duygu Bozkaya, Anne-Laure Tardy
Journal: Blood
Blood (2024) 144 (Supplement 1): 3967.
https://doi.org/10.1182/blood-2024-204580
Published: 2024
Journal Articles

Real-World Experience of Switching to Prophylactic Efanesoctocog Alfa in Patients with Moderate and Severe Hemophilia a: An Analysis of the Adelphi Hemophilia Wave III Disease Specific Programme

Maissaa Janbain, Miguel A. Escobar, Manuel Carcao, Andrew Wilson, Jennifer Dumont, Nathan Ball, Ella Morton, Duygu Bozkaya, Anne-Laure Tardy, Sylvie Bozzi
Journal: Blood
Blood (2024) 144 (Supplement 1): 131.
https://doi.org/10.1182/blood-2024-193764
Published: 2024
Journal Articles

Unmet Needs, Factor Consumption, and Healthcare Resource Use Among People with Hemophilia a: Real-World Analysis of the Adelphi Hemophilia Disease Specific Programme TM

Lynn Malec, Davide Matino, Kieran Wynne-Cattanach, Chris Blazos, Duygu Bozkaya, Anne-Laure Tardy, Sylvie Bozzi, Jennifer Dumont
Journal: Blood
Blood (2024) 144 (Supplement 1): 3973.
https://doi.org/10.1182/blood-2024-193803
Published: 2024
Journal Articles

Association between Hemophilia Joint Health Score and Quality of Life Using Results from the Xtend-1 Efanesoctocog Alfa Phase 3 Trial

Christoph Königs, Doris V. Quon, Cedric Hermans, Nana Kragh, Jérôme Msihid, Emilie Gerard, Duygu Bozkaya, Linda Bystrická, Cecile Le Camus, Elena Santagostino, Annemieke Willemze, Annette von Drygalski
Journal: Blood
Blood (2024) 144 (Supplement 1): 719.
https://doi.org/10.1182/blood-2024-193761
Published: 2024
Journal Articles

Cost-Effectiveness of Deferasirox (Exjade®) Versus No Chelation In Patients with Lower Risk Myelodysplastic Syndromes (MDS): A Canadian Perspective

Khalid El Ouagari, PhD, Kristen Migliaccio-Walle, BS, Helen Lau, MS, Duygu Bozkaya, MBA, MSc
Journal: Blood
Blood (2010) 116 (21): 4962.
https://doi.org/10.1182/blood.V116.21.4962.4962
Published: 2010
Journal Articles

Impact of Management of Iron Overload in Patients with Myelodsplastic Syndromes

Duygu Bozkaya, Kristen Migliaccio-Walle, Jean-Franòois Baladi
Journal: Blood
Blood (2008) 112 (11): 1308.
https://doi.org/10.1182/blood.V112.11.1308.1308
Published: 2008